As one wise pundit recently observed, "everybody is a virologist now." For the many people whose interest in biology formerly began and ended with "the mitochondria is the powerhouse of the cell," a second axiom can now be ...
Inasmuch as therapeutic options against coronavirus have been focused mainly on blocking the interaction between its spike protein and the ACE2 receptor on host cells, SARS-CoV-2 has several additional critical proteins that ...
Using the Cerro Tololo Inter-American Observatory (CTIO), Russian astronomers have conducted a chemical study of the galactic globular cluster NGC 6652. Results of the study, presented in a paper published April 13 on arXiv.org, ...
New variants of the coronavirus that caused the COVID-19 pandemic continue to emerge. To combat them, researchers are doing everything they can to find new therapies that can target a broad range of different coronavirus ...
Cell & Microbiology
May 1, 2023
0
32
New computer models and simulations from Los Alamos National Laboratory are showing researchers how the virus that causes COVID-19 manages to use its spike protein to fuse with and infect human cells. To be presented at the ...
Biochemistry
Mar 7, 2022
0
462
Uppsala researchers have succeeded in designing a molecule that inhibits the replication of coronaviruses and has great potential for development into a drug suitable for treating COVID-19. The molecule is effective against ...
Biochemistry
Feb 10, 2022
0
204
Beneath the SARS-CoV-2 membrane and its spikes lurks a squiggle of genetic material, or RNA, enveloped by a protein that acts like bubble wrap to protect the genetic material. This protein also acts as a "hotbed" for multiple ...
Molecular & Computational biology
Jan 18, 2022
0
678
A team of researchers from Politecnico di Milano, the University of California and Massey University has created maps of possible hotspots in Asia and Europe where the risk of coronaviruses jumping from bats to humans is ...
Researchers at the Vienna BioCenter designed a testing protocol for SARS-CoV-2 that can process tens of thousands of samples in less than 48 hours. The method, called SARSeq, is published in the journal Nature Communications ...
Cell & Microbiology
May 25, 2021
0
17
The swift development of vaccines has provided a vital tool to combat the spread of the deadly SARS-CoV-2 virus, but challenges to reaching herd immunity posed by the rise of new mutations and the inability of immunosuppressed ...
Biochemistry
May 24, 2021
0
16
